Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Asset Utilization Ratio (2020 - 2023)

Historic Asset Utilization Ratio for Benitec Biopharma (BNTC) over the last 5 years, with Q1 2024 value amounting to 0.0.

  • Benitec Biopharma's Asset Utilization Ratio fell 9430.1% to 0.0 in Q1 2024 from the same period last year, while for Mar 2024 it was 0.0, marking a year-over-year decrease of 9430.1%. This contributed to the annual value of 0.01 for FY2023, which is 16924.76% up from last year.
  • Per Benitec Biopharma's latest filing, its Asset Utilization Ratio stood at 0.0 for Q1 2024, which was down 9430.1% from 0.0 recorded in Q4 2023.
  • Benitec Biopharma's Asset Utilization Ratio's 5-year high stood at 0.01 during Q3 2020, with a 5-year trough of 0.0 in Q3 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.0, with a median of 0.0 in 2022.
  • In the last 5 years, Benitec Biopharma's Asset Utilization Ratio crashed by 9832.69% in 2021 and then surged by 287108.0% in 2022.
  • Quarter analysis of 5 years shows Benitec Biopharma's Asset Utilization Ratio stood at 0.0 in 2020, then tumbled by 56.17% to 0.0 in 2021, then skyrocketed by 134.93% to 0.0 in 2022, then crashed by 38.98% to 0.0 in 2023, then plummeted by 84.72% to 0.0 in 2024.
  • Its last three reported values are 0.0 in Q1 2024, 0.0 for Q4 2023, and 0.0 during Q3 2023.